Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
International Journal of Medical Informatics
|
April 9, 2025
Predicting hospital admissions, ICU utilization, and prolonged length of stay among febrile pediatric emergency department patients using incomplete and imbalanced electronic health record (EHR) data strategies
Tom Velez, Zara Ibrahim, Kanayo Duru, et al.
Vaccine: X
|
May 5, 2022
The potential cost-effectiveness of HPV vaccination among girls in Mongolia
Munkh-Erdene Luvsan, Elisabeth Vodicka, Uranbolor Jugder, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
December 8, 2010
Deposition, imaging, and clearance: what remains to be done?
Gerhard Scheuch, William Bennett, Lars Borgström, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
November 28, 2018
Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?
Jeffry G Weers, Yoen-Ju Son, Mark Glusker, et al.
Mabs
|
March 30, 2017
A new anti-mesothelin antibody targets selectively the membrane-associated form
Kamal Asgarov, Jeremy Balland, Charline Tirole, et al.
Molecular Pharmaceutics
|
May 24, 2022
iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes
Per Bäckman, Antonio Cabal, Andy Clark, et al.
Molecular Pharmaceutics
|
May 16, 2022
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
Jayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Molecular Pharmaceutics
|
December 7, 2023
iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
Jayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Molecular Pharmaceutics
|
March 13, 2025
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products
Ben Forbes, Per Bäckman, Antonio Cabal, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
International Journal of Medical Informatics
|
April 9, 2025
Predicting hospital admissions, ICU utilization, and prolonged length of stay among febrile pediatric emergency department patients using incomplete and imbalanced electronic health record (EHR) data strategies
Tom Velez, Zara Ibrahim, Kanayo Duru, et al.
Vaccine: X
|
May 5, 2022
The potential cost-effectiveness of HPV vaccination among girls in Mongolia
Munkh-Erdene Luvsan, Elisabeth Vodicka, Uranbolor Jugder, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
December 8, 2010
Deposition, imaging, and clearance: what remains to be done?
Gerhard Scheuch, William Bennett, Lars Borgström, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
November 28, 2018
Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?
Jeffry G Weers, Yoen-Ju Son, Mark Glusker, et al.
Mabs
|
March 30, 2017
A new anti-mesothelin antibody targets selectively the membrane-associated form
Kamal Asgarov, Jeremy Balland, Charline Tirole, et al.
Molecular Pharmaceutics
|
May 24, 2022
iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes
Per Bäckman, Antonio Cabal, Andy Clark, et al.
Molecular Pharmaceutics
|
May 16, 2022
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
Jayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Molecular Pharmaceutics
|
December 7, 2023
iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
Jayne E Hastedt, Per Bäckman, Antonio Cabal, et al.
Molecular Pharmaceutics
|
March 13, 2025
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products
Ben Forbes, Per Bäckman, Antonio Cabal, et al.
Page
of 6